AstraZeneca and Oracle collaborate on AI for drug trial patient recruitment

• AstraZeneca and Oracle are collaborating on AI to find patients for drug trials.
• The partnership aims to refine clinical research using AI.
• The deal is part of a growing trend of AI health collaborations between drug companies and tech firms.
• The agreement is currently in a non-binding phase, with terms not yet finalized.
• The partnership seeks to leverage AI and real patient health data for faster patient recruitment.